The effect of the third dose of the BNT162b2 vaccine on anti-SARS-CoV-2 spike antibody levels in healthcare workers with and without COVID-19 infection-Reference-Cited by-同舟云学术

The effect of the third dose of the BNT162b2 vaccine on anti-SARS-CoV-2 spike antibody levels in healthcare workers with and without COVID-19 infection

Published:2023-02-23 Issue:1 Volume:55 Page:722-732
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Wolszczak-Biedrzycka Blanka¹²,Bieńkowska Anna¹²,Cieślikiewicz Beata¹,Smolińska-Fijołek Elwira³,Biedrzycki Grzegorz⁴,Dorf Justyna⁵

Affiliation:

1. Department of Psychology and Sociology of Health and Public Health, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland

2. The Oncology Center of the Region of Warmia and Mazury in Olsztyn, Hospital of the Ministry of the Interior and Administration, Olsztyn, Poland

3. Department of Physiology, Medical University of Gdańsk, Gdańsk, Poland

4. Hospital Dispensary, Regional Specialist Hospital in Olsztyn, Olsztyn, Poland

5. Department of Clinical Laboratory Diagnostics, Medical University of Białystok, Bialystok, Poland

Funder

Roche Diagnostics

Hospital of the Ministry of the Interior and Administration in Olsztyn

University of Warmia and Mazury in Olsztyn

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2023.2182907

Reference42 articles.

1. [cited 2021 Jun 10]. Available from: http://www.gov.pl/>web>szczepimysie

2. SARS-CoV-2 variants, spike mutations and immune escape

3. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults

4. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

5. Waning Immunity after the BNT162b2 Vaccine in Israel